Transcript Highlights:

• Essentially, this new legal definition explicitly includes industrial hemp, not used for cannabinoid
• total 0.3% concentration, intermediate hemp-derived total THC concentration, final hemp-derived cannabinoid
• total 0.3% concentration, intermediate hemp-derived total THC concentration, final hemp-derived cannabinoidal
• So essentially, farmers or producers who use hemp for those legalized non-cannabinoid purposes like paper
• prohibited, and those are the states in red, to pink, meaning the state follows the FDA prohibition of cannabinoids

Keywords: Cannabis Retail Market, Joint Commission to Oversee the Transition of the Commonwealth into a, 976, house, all

Transcript Highlights:

• AB 8 provides a clear, enforceable structure for regulating intoxicating cannabinoid products while also
• What AB 8 currently proposes, however, is to allow intoxicating cannabinoids to be sourced from an unlicensed
• However, is to allow intoxicating cannabinoids to be sourced from an unlicensed source, a hemp cultivator
• Effectively, by allowing hemp-derived cannabinoids to enter the legal cannabis market, AB 8 would result
• Effectively, by allowing hemp-derived cannabinoids to enter the legal cannabis market, AB 8 would result

Summary: The Assembly Committee on Revenue and Taxation met as a subcommittee and heard several bills, with members explaining that measures with significant fiscal impacts would be held for suspense or taken up later. AB 761 would let the Monterey-Salinas Transit District place a local sales tax measure on the ballot with approval from two-thirds of its board rather than needing approval from each member jurisdiction; supporters said it would preserve transit funding for veterans, seniors, and people with disabilities, while an opponent argued it would make it easier to raise a regressive tax. The bill was voted out 5-2 after being called for absent members. AB 1253, which would clarify property tax treatment for wildfire reconstruction beyond substantial equivalence, drew support from the Los Angeles County Assessor and the California Assessors Association but was sent to suspense. AB 8, dealing with hemp enforcement, intoxicating hemp products, and integration of hemp cannabinoids into the cannabis supply chain and tax system, drew strong support from cannabis operators and labor groups and opposition from small cultivators and public health advocates concerned about supply, tax revenue, and voter intent; it was also sent to suspense. The committee then heard AB 1138, a major expansion and modernization of the film and television tax credit program. Supporters, including entertainment unions, workers, studios, and local officials, said the bill would help keep production and jobs in California amid competition from other states and countries; opponents criticized it as picking winners and losers and argued broader business costs were the real problem. The bill was referred to suspense. AB 829, which would create a California Parkinson’s Disease Research Fund and voluntary tax contribution program to support research and services, received unanimous support from advocates and was approved 6-0 to Appropriations. AB 474 would exempt rental income from nonprofit home-sharing programs for low-income homeowners from state income tax and protect participants’ eligibility for certain benefits; supporters said it could help older adults age in place and address housing shortages, and the bill was sent to suspense after members asked for clarification on the fiscal estimate. The committee also heard AB 376, which would exempt wildfire settlement payments from state income tax for certain disaster survivors; supporters from rural counties said the money is meant to help victims rebuild and should not be taxed, and the bill was referred to suspense. Finally, AB 480 would allow developers using low-income housing tax credits to switch from allocated to certificated state credits after an award, with supporters saying it would maximize private investment and stretch housing dollars further; it too was sent to suspense. Throughout the hearing, members repeatedly emphasized the need to balance policy goals with fiscal impacts, and several bills were held or referred to suspense rather than voted out immediately.

Transcript Highlights:

• A continued challenge is that there are multiple cannabinoid markets in California.
• More recently, a market has emerged for hemp-derived cannabinoids.
• And within the unlicensed cannabinoid markets, products may be sold to kids or contain harmful ingredients
• There have been discovered such issues as cannabinoid hyperemesis syndrome.
• There's other intoxicating cannabinoids that may have more harmful risk, and it's doing all of those

Summary: The joint informational hearing focused on the Department of Cannabis Control’s report on the condition and health of California’s cannabis industry. Department staff reviewed the evolution of state cannabis law, the creation of the current regulatory framework, licensing and compliance efforts, and enforcement against illicit cannabis and hemp-derived intoxicating cannabinoids. The department said the licensed market has grown in production and retail units sold, while active licenses and retail sales value have declined, and that the illicit market remains a major competitive factor. The department also highlighted consumer education efforts, product testing and recalls, and coordination through the state enforcement task force and other agencies. The department’s economist said the data show continued growth in licensed production and a rising share of consumption through the licensed market, but falling wholesale and retail prices have reduced overall industry value. He identified major headwinds as taxes and fees, illicit-market competition, local prohibitions that limit retail access, regulatory costs, and broader business pressures, while noting opportunities in product innovation and possible hemp-market changes. Committee members pressed the department on enforcement, public health concerns, equity ownership and employment, delays in grant administration, pesticide testing, and whether the legal market is truly viable for small businesses and farmers. Several members argued that stronger enforcement and lower costs are needed, while one member raised concerns about cannabis-related health harms and said the hearing focused too narrowly on supply-side issues. Public commenters from industry groups and advocacy organizations largely echoed concerns about high taxes, regulatory burdens, limited retail access, and the size of the illicit market. Many urged the Legislature not to let the excise tax rise from 15% to 19% and called for tax relief, compliance reform, more enforcement, and broader retail access. Some speakers said the report was too optimistic and did not reflect business failures, debt, and closures, while others emphasized the need to protect small farmers, address wildfire insurance, and support equity businesses. No votes or formal actions were taken; the hearing was informational only.

Transcript Highlights:

• <00:07:59.280> products policy that medical cannabinoid products policy that medical cannabinoid
• Usually focused on cannabinoid cannabidiol. You'd think I would be able to say those words by now.
• , CBG, CBN, and other, most importantly, non-intoxicating cannabinoids.
• To be clear, this is about non-intoxicating hemp-derived cannabinoids.
• So, these are products that may have half and half THC, CBD, CBG, other cannabinoids.

Keywords: 1187, senate, all

Transcript Highlights:

• One of the bills would allow the ATCs to outsource non-intoxicating hemp-derived cannabinoids like CBD
• One of the bills would allow the ATCs to outsource non-intoxicating hemp-derived cannabinoids like CBD
• One of the bills would allow the ATCs to outsource non-intoxicating hemp-derived cannabinoids like CBD
• One of the bills would allow the ATCs to outsource non-intoxicating hemp-derived cannabinoids like CBD
• intoxicating hemp derived cannabinoids intoxicating hemp derived cannabinoids like<01:11:44.960>

Keywords: 928, house, all

Summary: The Health and Human Services Oversight Committee met on February 2 and first approved the draft minutes from the prior meeting, with minor corrections to the meeting date and attendance notation. DHHS Associate Commissioner Patricia Tilly then gave a department update, describing the current uncertainty around federal priorities and funding, and provided two substantive reports: progress on the new Hampstead Youth Development Center and an update on the department’s review of an ALS registry proposal. She said the YDC project is underway with tree clearing, fencing, stormwater and site-prep work, and remains on track for completion by June 30, 2026 and operation by August 30, 2026. The center currently has 12 youth, and the new design is intended to provide flexibility for fluctuating census levels. On ALS, Tilly explained that HB 576 had prompted the department to examine whether a registry could be built, but the estimated cost of a HIPAA-compliant system was about $750,000. She said DHHS is reviewing whether existing data sources, such as hospital discharge data and CHIS claims data, could provide useful information, but noted both are incomplete for registry purposes. Committee members discussed whether the Rare Disease Advisory Council, Dartmouth, or existing cancer registry infrastructure could help reduce costs. DHHS said it is neutral and willing to continue exploring alternatives, while members emphasized the value of a registry and the need to consider shared infrastructure and funding. The committee also heard from Jenny Horan of the Alzheimer’s Association, who presented the subcommittee’s report on Alzheimer’s disease and related dementias. She said the subcommittee spent the past year gathering information on dementia care, abuse and exploitation issues, caregiver strain, and available services, and is now moving into a second phase focused on identifying gaps and developing a state plan. Members asked about geriatric psychiatric capacity and long-term care availability; Horan said the state has limited capacity and that the plan will help clarify where needs are greatest. She offered to return for follow-up questions at a later meeting. Finally, Olivia May of DHHS presented the quarterly report on the 12-month postpartum Medicaid coverage extension. She said New Hampshire implemented the extension after federal and state action, and the first claims data are still emerging because of reporting lags. In the initial cohort studied, 95% received some medical services during the extended period, 52.4% received mental health or substance use disorder treatment, 26.7% received preventive visits, and 3.2% received heart or hypertension services. Members asked about return on investment and whether higher federal matching rates are being used appropriately; DHHS said it claims the highest possible match based on eligibility group and will return with more data over time. The committee then heard the annual therapeutic cannabis program report from Michael Holt, who said the program had 1,475 registered patients as of June 30, 2024 and that growth has slowed, with New Hampshire having the lowest per-capita medical cannabis enrollment nationally.

Transcript Highlights:

• The issue that we spotted is in the current hemp law: artificial cannabinoids and synthesized cannabinoids
• have separate meanings, and so an artificial cannabinoid would be a cannabinoid that's created from
• an existing natural cannabinoid, which is converting a CBD cannabinoid that's extracted from hemp into
• And then synthetic cannabinoids is defined as something created from something not pulled from cannabis
• The current hemp law prohibits the use of synthetic and artificially derived cannabinoids in manufactured

Keywords: 910, house, all

Summary: The committee on Consumer Protection and Commerce met on February 5, 2025, and heard testimony on several bills. HB 918, relating to labeling, drew support from the Department of Health, INDA (the nonwoven fabrics industry), and Hawaii Realtors. INDA said the bill aligns with do-not-flush labeling laws in other states but raised a concern about the six-month compliance deadline tied to FIFRA approval. In response to committee questions, witnesses explained that the bill is aimed mainly at disinfecting wipes, that most products are already labeled nationally, and that the proposed timing issue could be addressed by using Oregon’s approach. No vote was taken on the measure during the portion shown. The committee also heard HB 1482, relating to controlled substances. HPD supported the bill, and Aloha Green Holdings and the Department of Health both said they supported the intent but recommended technical amendments. Their testimony focused on clarifying the treatment of Delta-8 THC, distinguishing synthetic or artificially derived cannabinoids from naturally occurring forms, and avoiding confusion in the hemp law. Members asked whether Delta-8 would show up on drug tests; witnesses said it would test positive for THC and would not be distinguished from Delta-9. The bill was then set aside as the committee moved on. HB 981, relating to attorney’s fees, drew opposition from a law firm representing homeowners and associations, which argued the bill would limit access to legal services, favor developers and contractors, and make settlement harder. The witness suggested instead using existing consumer-protection fee-shifting concepts, and committee members explored whether a capped fee award or a broader attorney-fee rule would be more appropriate. The committee then took up HB 807 and HB 336, both relating to condominiums. HB 807 received support from the Green Infrastructure Authority and the Hawaii Bankers Association, while one testifier urged deferral over unresolved questions about commercial PACE financing; the bank association asked for more time to work with HGIA, and the chair indicated decision-making could be deferred to allow that discussion. On HB 336, the Community Associations Institute opposed the bill as removing checks and balances, while the Hawaii Workers Center and others supported it as a step toward clearer enforcement of health and safety issues in condominiums and rental housing.

Transcript Highlights:

• responsibilities and improve customer understanding, and adds clarity for enforcement of non-intoxicating cannabinoid
• There's no real health reason to prohibit sublingual application of non-intoxicating cannabinoids, and
• responsibilities and improve customer understanding, and adds clarity for enforcement of non-intoxicating cannabinoid
• Non-intoxicating cannabinoid products. And with that, I will toss it over to Mr. Tabell.
• There's no real health reason to prohibit sublingual application of non-intoxicating cannabinoids, and

Keywords: 1187, senate, all

Transcript Highlights:

• So, real quickly, this bill bans psychoactive cannabinoids except for what is legal hemp, which is less
• This will classify psychoactive cannabinoids from hemp as a schedule one drug, even if derived legally
• It restricts the sale of CBD and all non-psychoactive cannabinoid products to pharmacies only, eliminating

Bills: HB1

Keywords: DUI, driving under the influence, ignition interlock, interlock device, driver license suspension, restricted license, motor vehicle, alcohol offense, first offense, repeat offender, blood alcohol concentration, BAC, license revocation, Alabama State Law Enforcement Agency, ALEA, public safety, traffic safety, chemical dependency, substance abuse, court referral program

Bills: SR5, SB5, SB11, SB12, SB25, SB26, SB28, SB35, SB5, SB11, SB12, SB25, SB26, SB28, SB35, SB5, SB11, SB12, SB25, SB26, SB28, SB35, SR5

Keywords: redistricting, Senate procedures, public input, Texas Legislature, amendments, Texas Senate, congressional districts, legislative procedures, legislative transparency, Senate rules, public hearings, committee procedures, hemp regulation, consumable products, cannabinoids, occupational licenses, criminal offenses, SB 11, Texas attorney general, election crimes

Bills: SR5, SB5, SB11, SB12, SB25, SB26, SB28, SB35, SB5, SB11, SB12, SB25, SB26, SB28, SB35, SB5, SB11, SB12, SB25, SB26, SB28, SB35, SR5

Keywords: redistricting, Senate procedures, public input, Texas Legislature, amendments, Texas Senate, congressional districts, legislative procedures, legislative transparency, Senate rules, public hearings, committee procedures, hemp regulation, consumable products, cannabinoids, occupational licenses, criminal offenses, SB 11, Texas attorney general, election crimes

Transcript Highlights:

• There's clarification about some products like combined cannabinoids, ratio products, and large-format
• clarification about some products<00:02:56.320> like<00:02:56.440> combined<00:02:56.920> cannabinoids
• , products like combined cannabinoids, products like combined cannabinoids, ratio<00:02:58.120>

Keywords: 919, house, all

Summary: Senate File 4401, a cannabis bill, was presented as a broad maintenance package developed through months of work with more than 80 stakeholders, including small businesses, labor, tribal representatives, medical licensees, and the Office of Cannabis Management. The author said it makes a series of technical and policy adjustments, including support for small businesses, hemp QR codes, privacy protections, event coordinator changes, clearer product definitions, investor and timeline changes, and a bridge for hemp businesses to enter cannabis. It also addresses medical cannabis access by renaming medical combination licenses as macro licenses, eliminating the grow-and-sale ratio, correcting canopy estimates, requiring key products to be stocked, and creating a first step toward a medical psilocybin program with a report and federal funding directive. Representative West supported the bill overall but criticized the canopy reduction for medical combination licenses, arguing it changes the rules midstream and could lead to litigation and taxpayer costs. He said the bill helps social equity applicants by allowing more outside investment and described the hemp provisions as a way to save that industry. The author responded that the bill right-sizes a temporary system and reflects stakeholder agreement on needed changes. After discussion, the author again urged a green vote and thanked staff and prior cannabis workers for their help. There were no amendments at the desk, the bill was given a third reading, and the House passed Senate File 4401 by a vote of 92 ayes to 42 nays, with the title agreed to.

Transcript Highlights:

• STARTED COLLECTING LAST SESSION REFLECTS INDIVIDUALS IN THE STATE OF FLORIDA WHO HAVE DIED DUE TO CANNABINOIDS
• AND SYNTHETIC CANNABINOIDS.
• DUE TO THOSE CANNABINOIDS.
• THERE ARE OTHER DEATHS OF INDIVIDUALS WHO HAVE CANNABINOIDS IN THEIR SYSTEM BUT THAT'S NOT THE CAUSE

Keywords: 999, senate, all

Transcript Highlights:

• updating the warning labels to include cannabis-induced psychosis, chronic psychotic disorder, and cannabinoid
• people, if you use high doses, you risk various significant consequences, including psychosis and cannabinoid
• effects on developing brains, including cannabis use disorder, cannabis-induced psychosis, and cannabinoid
• effects on developing brains, including cannabis use disorder, cannabis-induced psychosis, and cannabinoid
• Harms like cannabis-induced psychosis, cannabinoid hyperemesis syndrome, increased ER visits, worsening

Keywords: 995, all

Summary: The Joint Committee on Cannabis Policy held its fourth hearing, with opening remarks from Senate Chair Adam Gómez and House Chair Dan Donahue emphasizing the committee’s broad agenda, including retail modernization, labor protections, advertising rules, sustainability, and financial resources. Testimony began with public health advocates supporting H.157/S.9 to ban cannabis billboard advertising, arguing that billboards normalize use for youth and are linked to cannabis-related harms such as psychosis, addiction, and cannabinoid hyperemesis syndrome. Witnesses cited research, family stories, and court decisions in Mississippi and Virginia upholding similar restrictions, while committee members questioned the scope of the state’s authority to regulate billboards on private property and the relevance of federal highway funding and federal cannabis law. The committee also heard testimony on H.175, a proposal to allow cannabis drive-through sales. A dispensary operator argued drive-throughs would improve access, especially for disabled customers and veterans, and said security and ID checks could be handled with cameras and staff screening. Committee members pressed him on how employees would assess impairment, whether drive-throughs could increase access for minors, and whether the industry should be treated like alcohol, with the witness responding that staff already refuse service to intoxicated customers and that education, not prohibition, is the better approach. Another bill, H.3982, would apply the bottle deposit law to carbonated hemp- or THC-infused beverages; the sponsor said the measure would standardize recycling requirements for products already sold in dispensaries and other markets, and members asked about container types and recycling compatibility. A major portion of the hearing focused on labor peace agreements, with UFCW representatives, cannabis workers, and Sen. Lydia Edwards supporting S.77/H.161. They said the bill would require cannabis businesses to remain neutral when workers seek to organize, arguing that unions improve safety, wages, benefits, and job stability in an industry they described as underregulated and prone to retaliation. Witnesses cited workplace hazards, wage theft, and the death of a worker at a Holyoke facility as examples of why stronger worker protections are needed. Committee members asked how the proposal differs from existing labor law, whether tying LPAs to licensing and renewal could create legal or administrative problems, and how other states handle similar requirements. No votes or final actions were taken during the hearing.

Transcript Highlights:

• does it ban, and it also criminalizes CBN, which is a natural, non-synthetic, non-intoxicant... cannabinoid
• The CBN, I'm not familiar with where the cannabinoids lay, the chemistry behind it.
• are in... intoxicating, and what natural cannabinoids are non-intoxicating.
• a successful model and as other research around the country starts looking into the different cannabinoids
• Synthetic cannabinoids are significant. more potent than grown cannabis and these products are ending

Bills: SCR5, SCR13, SB3, SB6, SB10, SB12, SB13, SB15, SB17, SB18, SB19, SB24, SB35, SB57, SB65, SB112, SB284, SB290, SB388, SB400, SB402, SB412, SB495, SB499, SB502, SB509, SB621, SB706, SB740, SB815, SB842, SB854, SB875, SB893, SB917, SB974, SB1025, SB1061, SB1073, SB1106, SB1268, SB1281, SB1300, SB1362, SB1379, SB1447, SB1451, SB1555, SB1902, SJR36, SJR12, SCR13, SCR25, SCR5, SCR22, SCR12, SCR24, SB495, SB412, SB10, SB18, SB565, SB372, SB842, SB765, SB62, SB19, SB666, SB707, SB888, SB687, SB706, SB847, SB290, SB13, SB1248, SB740, SB14, SB1006, SB504, SB917, SB925, SB388, SB1902, SB1121, SB995, SB857, SB305, SB296, SB284, SB35, SB6, SB815, SB3, SB1281, SB1379, SB1300, SB1497, SB1499, SB1498, SB1451, SB1061, SB15, SB65, SB241, SB304, SB402, SB499, SB621, SB974, SB1023, SB1024, SB1025, SB1106, SB686, SB112, SB371, SB204, SB400, SB609, SB1447, SB670, SB502, SB427, SB850, SB854, SB413, SB1555, SB1362, SB1346, SB1033, SB1220, SB1073, SB810, SB987, SB1539, SB893, SB447, SB875, SB406, SB509, SB985, SB965, SB17, SB1119, SB1505, SB12, SB24, SB57, SB1194, SB1253, SB1215, SB1532, SB1268, SB1302, SB856, SB650, SB583, SB673, SB840, SJR57, SCR8, SB213, SB681, SB1172, SB1252, SB378, SB610, SB918, SB1343, SB608, SB487, SB955, SB957, SB988, SB990, SB1019, SB1021, SB1120, SB251, SB958, SB535, SB761, SB1, SB541, SB315, SB379, SB1018, SB1737, SB266, SB1415

Keywords: SCR 5, Senate Concurrent Resolution 5, Texas School for the Deaf, TSD, Robert Rives, gymnasium naming, building naming, honorary resolution, commemorative resolution, deaf education, hard of hearing, Gallaudet University, alumni hall of fame, football coach, school facility naming, education K-16, State Affairs, Texas Legislature, public school tribute, water rights

Bills: SB 2, SB 3, SB 4, SB 5, SB 6, SB 7, SB 8, SB 9, SB 10, SB 11, SB 12, SB 13, SB 14, SB 15, SB 16, SB 17, SB 18, SB 34

Keywords: flash flood, flood warning, outdoor warning siren, emergency alert, disaster preparedness, flood mitigation, Hill Country floods, Texas Water Development Board, municipalities, counties, local government mandate, public safety, grant program, backup power, weather siren, emergency management, flood-prone area, warning system, redistricting, election

Transcript Highlights:

• and courage for states to move forward, but these are we're not talking about naturally derived cannabinoids
• that naturally occurs to the synthetic cannabinoid, but Essentially these are unregulated, untested,
• Opioid, not opioids, got it, but um, cannabinoids, pardon me.
• Um, there are some cannabinoids that are derived from hemp that are the same or similar that are derived
• there's ways that we could see still a legal hemp market without synthetic or intoxicating derived cannabinoids

Transcript Highlights:

• There is a clarification that combined cannabinoids allow up to 400 mg in drinks that are less than 1,000
• MG OF EACH The cannabinoid, or those that are combined, these are actually limits that are set in law
• Importantly, we also allowed the hemp-derived cannabinoids to be used in adult use as they are allowed
• Importantly, we also allowed the hemp-derived cannabinoids to be used in adult use as they are allowed
• Importantly, we also allowed the hemp-derived cannabinoids to be used in adult use as they are allowed

Keywords: 1187, senate, all

Transcript Highlights:

• from such non-intoxicating cannabinoids shall be tested for contaminants and cannabinoid profile in
• from such non-intoxicating cannabinoids shall be tested for contaminants and cannabinoid profile in
• from such non-intoxicating cannabinoids shall be tested for contaminants and cannabinoid profile in
• So the synthetic cannabinoid is an ingredient, right?
• Well, they can't buy synthetic cannabinoids because we don't let them yet.

Keywords: 1191, senate, all

Transcript Highlights:

• A lot of times meth or synthetic cannabinoids, K2, is actually soaked on pages.
• Choate said, you know, this day and age, you talk about things like synthetic cannabinoid, and to some
• But make no mistake, as committee members know, these synthetic cannabinoids that are coming into the
• system, there's no FDA-approved formula for making these synthetic cannabinoids, and oftentimes what
• Unfortunately, though, a lot of times it is just the synthetic cannabinoids. Okay.

Keywords: 1185, senate, all

Transcript Highlights:

• clarification on the requirements of ID scanning at cannabis sales facilities, the definition of synthetic cannabinoid
• clarification on the requirements of ID scanning at cannabis sales facilities, the definition of synthetic cannabinoid
• Section 10.3, synthetic cannabinoids.
• inclusion of additional defining language, expands what is not included in the definition of synthetic cannabinoids

Keywords: 909, all